Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Nephrology | Obstetrics/Gynecology (Women’s Health) | Urology | Family Medicine
Disease Category: Urinary Incontinence
Location: United States, IN
Clinical Trial Details
Research Study Summary
Study to confirm the efficacy of Fesoterodine 4 mg compared to 8 mg.
The purpose of this study is to compare the effectiveness of two doses of a drug called Fesoterodine and placebo (a substance that contains no active ingredient but looks identical to the study drug) for overactive bladder. In order to achieve this evaluation in an unbiased manner, you will be randomly assigned to one of 3 groups: Fesoterodine 4 mg, Fesoterodine 8 mg, or Placebo.
Patient Inclusion Criteria:
- Male or female over the age of 18
- Overactive bladder for over 6 months
- Subject must LEAK
Patient Exclusion Criteria:
- A neurological condition
- History of lower urinary tract or pelvic surgery
- History of IC, bladder stones, or urinary retention
- Bladder outlet obstruction
To Learn more
Both Male and Female
Date Last Changed:
May 2, 2014
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.